CU6 - General discussion, page-258

Irrespective of MFs track record or the value of their article, CU6 has achieved the said feat in "the worst biotech winter" macro conditions. Since the IPO kept falling in the macro environment but the mgmt marched to a different drummer and have executed awesomely and there is a packed agenda for 2024/5. So can we say now that the SP is trying to catch-up to the fundamentals and not about the rising tide lifting CU6 as this boat has risen gradually instead of a spike (unless there are motivated big buyers or players gaming the price). So while there will be days/ weeks over which there may be consolidation, the macro may provide potential tailwinds to the FA.

One can also conjecture that those that saw the success of say Telix and may want in on the next best thing (in their opinion, not mine) or there could be dollars flowing into biotech as the Lithium stocks are in the dumps....could be any combination of reasons why there is a bit of a rush on this counter.

Note, the macro is not just the biotech winter thawing but also the state of the radio-diagnostics industry as the unavailability of Pluvicto or the shortage of the radio-diagnostic juniors readily available for BP for M&A, and on top of that BP sitting on hundreds of billions (if not a Trillion) in cash waiting to plug/ expand their pipeline.

AIMO.